Investing.com - Chenguang Biotech Group reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Chenguang Biotech Group announced earnings per share of ¥0.18 on revenue of ¥1.57. Analysts polled by Investing.com EPS of ¥0.18 on revenue of ¥1.25B.
Chenguang Biotech Group 's are down 16.97% and is trading at ¥16.96 , still down 5.62% from its 52 week high of ¥17.97 set on Wednesday, March 2, 2022.
Chenguang Biotech Group shares gained 3.98% to trade at ¥16.96 in intra-day trade the report.
Chenguang Biotech Group follows other major Consumer Staples sector earnings this month
Chenguang Biotech Group's report follows an earnings missed by Kweichow Moutai on Monday, October 17, 2022, who reported EPS of ¥11.63 on revenue of ¥30.34B, EPS of ¥12.13 on revenue of ¥31.69B.
Foshan Haitian Food had missed expectations on Thursday with third quarter EPS of ¥0.28 on revenue of ¥5.56B, for EPS of ¥0.3611 on revenue of ¥6.78B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar